How Long Does Semaglutide Take to Kick In — and What to Expect First

Semaglutide reaches detectable levels in the bloodstream within one to three days of an injection, but the appetite-lowering effect takes longer to become noticeable.
The starter doses (0.25 mg and 0.5 mg) are designed to let your body adjust, not to deliver the full effect — meaningful hunger reduction usually builds from the 1 mg dose onward.
Weight loss in clinical trials averaged around 15% of body weight over 68 weeks at the 2.4 mg maintenance dose, with progress continuing throughout that period.
Slow, steady progress is normal and expected, people who feel little change in the first two weeks are not failing; the titration schedule is doing its job.

Semaglutide starts working in your body within days of the first injection, but noticeable changes (reduced hunger, weight loss you can measure) typically take four to eight weeks to become clear. Most people in the STEP 1 trial, published in the New England Journal of Medicine, began to see meaningful weight reduction by around weeks four to eight, with results building steadily over the following months. These are prescription-only medicines: a prescriber assesses your suitability before treatment starts, and the pace of your progress is something to review with them.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What's actually happening week by week, and when to expect more

The biggest myth: if it hasn't worked in a fortnight, it isn't working

The most common source of disappointment with semaglutide is expecting the effect to arrive quickly and evenly. It doesn't. The titration schedule for Wegovy starts at 0.25 mg precisely because the first priority is tolerability, not weight loss. At that dose, many people feel very little change in appetite, and the scales may barely move. That is not a sign the medicine isn't working. It's the design.

GLP-1 medicines work by slowing gastric emptying, reducing appetite signals and improving the hormonal response to food. Those effects accumulate. The body isn't a light switch. By the time most patients reach 1 mg, usually around week nine, appetite suppression becomes noticeably stronger. By the time they reach the 1.7 mg and then 2.4 mg maintenance doses, the clinical effect is more substantial. Expecting the 0.25 mg starter pen to deliver the results of the 2.4 mg maintenance dose is like expecting a single rehearsal to equal opening night. The NHS semaglutide patient page is clear that this slow build is intentional and normal.

If you're reading timelines on forums and comparing them to your own first few weeks, bear in mind that the posts getting the most engagement tend to be the outliers, the very fast responders and the people who struggled. Neither tells you what your own response will look like. Give the titration schedule time to do its job.

The realistic week-by-week picture

Weeks one to four are generally about settling in. The most frequently reported experiences are mild nausea after the injection, a slight reduction in appetite and the odd moment of feeling full sooner than usual at a meal. Some people notice nothing much at all. Both are within the range of normal. It helps to keep your pen in a consistent place (a fridge shelf you actually open, rather than tucked at the back) so weekly injections become part of a routine rather than something to hunt for.

Weeks five to twelve typically bring the first visible changes for most people, especially once the dose increases to 0.5 mg and then 1 mg. Appetite shifts become more reliable: meals feel satisfying with smaller portions, and cravings for high-calorie foods often ease. The scales may start showing a 1–2 kg change per month at this stage, though individual variation is wide. People who want a more detailed breakdown of early changes can find it on our semaglutide: how long it takes to work page.

Beyond twelve weeks, and through to the 1.7 mg and 2.4 mg doses, weight loss tends to accelerate. The STEP 1 trial reported an average reduction of around 15% of starting body weight over 68 weeks, but that is an average, plotted across many months of steady progress, not a number reached quickly. For those curious about how long Wegovy takes to kick in and whether that matches their own experience so far, the picture over a full year is more informative than any single month.

What can slow the effect down, and what that means for your expectations

Several factors affect how quickly semaglutide's effect becomes apparent. Starting weight matters: someone with a higher BMI may lose a greater absolute number of kilograms before reaching the same percentage as someone closer to the threshold. Dietary patterns play a role too. The medicine reduces appetite; it doesn't override the effect of consistently high-calorie intake entirely. Physical activity, sleep, and stress levels all interact with appetite regulation, and GLP-1 medicines work within that wider system.

Missed injections reset momentum. Semaglutide has a half-life of roughly a week, so a missed dose doesn't immediately undo progress, but two or three missed injections over a month will blunt the steady-state effect. What counts as a missed dose and what to do about it is covered in the Patient Information Leaflet and is worth discussing with your prescriber rather than guessing. Our results timeline page goes into more detail on what shapes the speed of response.

It is also worth knowing that for some people the appetite effect arrives before any measurable weight change appears. Feeling less driven to snack, finishing a meal with food still on the plate, or thinking about food less often are all signs the medicine is active, and our page on how fast semaglutide kicks in explains why these early signals can appear before the scales move. If you are still uncertain whether semaglutide is right for you, or want to understand the broader options, the weight-loss treatment overview covers the full landscape.

When a prescriber review makes sense

If you have reached 1 mg and notice no reduction in appetite after a full month at that dose, that is worth raising with your prescriber. It is relatively uncommon, but some people do respond more slowly, and a clinical review can help identify whether the issue is the dose, an interaction, a lifestyle factor, or simply a need for more time. The guidance from NICE (TA875) suggests considering whether to continue treatment if less than 5% weight loss has occurred after six months on the maintenance dose. That is a clinical decision, not a self-help one.

At nume, every repeat prescription involves a genuine clinical review of your progress. If results are slower than expected, that conversation happens before your next pen is dispensed. Our clinical team can also help you understand whether a dose adjustment or a different approach to the lifestyle elements alongside treatment might make a difference. A broader look at how semaglutide's onset compares across different patient situations may also be useful reading. If you'd like to discuss your own circumstances, start a free consultation and a prescriber will review your case the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions